Serology
Hepatitis – Hepatitis B serology
Clinical material provided (Liquid Serum / Plasma – 1.5 mL) to assess the detection of Hepatitis B using serological markers
Frequency / Number of samples
6 surveys / 2 samples per survey
Tests
HBsAg-Screening, HBsAg-Supplementary, HBsAg-Confirmatory, Anti-HBs, Anti-HBc, Anti-HBc IgM, HBeAg, Anti-HBe, Hepatitis B Interpretation
Hepatitis – Hepatitis C serology
Clinical material provided (Liquid Serum / Plasma – 0.5 mL) to assess the detection of Hepatitis C using serological markers
Frequency / Number of samples
6 surveys / 2 samples per survey
Tests
HCV Ag, HCV Ag-Ab Assay, Anti-HCV-Screening, Anti-HCV-Supplementary, Anti-HCV-Confirmatory, Hepatitis C Interpretation
Hepatitis – Hepatitis D serology
Clinical material (Liquid Serum / Plasma – 0.5 mL) provided to assess the detection of Hepatitis D using serological markers
Frequency / Number of samples
1 survey / 2 samples per survey
Tests
Anti-HDV Total Antibody, Anti-HD IgM, HDAg-Screening, HDAg-Supplementary, HDAg-Confirmatory, Hepatitis D Interpretation
Hepatitis – Hepatitis E serology
Clinical material provided (Liquid Serum / Plasma – 0.3 mL) to assess the detection of Hepatitis E using serological markers
Frequency / Number of samples
1 survey / 2 samples per survey
Tests
Anti-HEV Total Antibody, Anti-HEV IgG, Anti-HEV IgM, Hepatitis E Interpretation
Infectious Mononucleosis
Clinical material provided (Liquid Serum / Plasma – 0.2 mL) to assess the detection of Infectious Mononucleosis
Frequency / Number of samples
6 surveys / 2 samples per survey
Tests
Infectious Mononucleosis ICT, Agglutination, Latex
Lymphadenopathy – Cytomegalovirus serology
Clinical material provided (Liquid Serum / Plasma – 0.6 mL) to assess the detection of Cytomegalovirus using serological markers
Frequency / Number of samples
4 surveys / 2 samples per survey
Tests
Cytomegalovirus IgG, Cytomegalovirus Total Antibody, Cytomegalovirus IgM Screening, Cytomegalovirus IgM Supplementary, Cytomegalovirus Confirmatory, Cytomegalovirus Avidity, CMV Interpretation
Lymphadenopathy – Epstein Barr Virus serology
Clinical material provided (Liquid Serum / Plasma – 0.6 mL) to assess the detection of Epstein Barr Virus using serological markers
Frequency / Number of samples
4 surveys / 2 samples per survey
Tests
EBV VCA IgG, EBV VCA IgM, EBV EBNA IgG, Heterophile Antibody, EBV EA IgG, EBV EBNA IgM, EBV Avidity, EBV EA and EBNA IgA, EBV EA IgA, EBV VCA IgA, EBV Interpretation
Lymphadenopathy – Toxoplasma serology
Clinical material provided (Liquid Serum / Plasma – 0.6 mL) to assess the detection of Toxoplasma using serological markers
Frequency / Number of samples
4 surveys / 2 samples per survey
Tests
Toxoplasmosis IgG, Toxoplasmosis Total Antibody, Toxoplasmosis IgM Screening, Toxoplasmosis IgM Supplementary, Toxoplasmosis IgA, Toxoplasmosis Avidity, Toxoplasmosis Interpretation
Molecular Infectious Diseases – Alphavirus & Flavivirus NAT
Simulated clinical material provided (Liquid Inactivated viral culture lysate – 0.25 mL) to assess the detection and identification of Alphaviruses and Flaviviruses using molecular assays
Frequency / Number of samples
2 surveys / 6 samples per survey
Tests
Alphavirus Group, Barmah Forest Virus, Chikungunya Virus, Ross River Virus, Sindbis Virus, Flavivirus Group, Dengue Virus, Japanese Encephalitis Virus, Kunjin Virus, Murray Valley Encephalitis Virus, Yellow Fever Virus, West Nile Virus, Zika Virus, Final Interpretation
Molecular Infectious Diseases – Gastrointestinal Viral Pathogens
Simulated clinical material provided (Liquid Inactivated viral culture lysate – 0.5 mL) to assess the detection of Gastrointestinal Viral Pathogens using molecular assays
Frequency / Number of samples
1 survey / 6 samples per survey
Tests
Gastrointestinal Viral Pathogens Multiplex Assays, Adenovirus, Astrovirus, Norovirus, Rotavirus, Sapovirus, Final Interpretation
Molecular Infectious Diseases – Hepatitis B DNA (Qualitative/ Quantitative)
Clinical material provided (Liquid Plasma – 1.2 mL) to assess the qualitative and quantitative detection of Hepatitis B DNA
Frequency / Number of samples
2 surveys / 6 samples per survey
Tests
HBV Qualitative DNA, HBV Quantitative DNA
Molecular Infectious Diseases – Hepatitis C Genotyping
Clinical material provided (Liquid Plasma – 1.2 mL) to assess the genotype of Hepatitis C
Frequency / Number of samples
2 surveys / 6 samples per survey
Tests
Hepatitis C genotyping
